Zackie Achmat’s T shirt reads: HIV positive. It is, pun intended, a positive message. South Africa’s most influential AIDS activist wants people to know that the dreaded disease can be faced, can be ...
Pharmaceutical Technology on MSN

UK approves Gilead’s twice-yearly HIV PrEP drug

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...
Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. A twice-yearly injection of a drug known as lenacapavir offered ...
DUBLIN--(BUSINESS WIRE)--The "HIV Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for HIV Drugs was valued at US$32.8 Billion in ...
A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.
WASHINGTON (Reuters) - About 1.2 million people in countries hard hit by AIDS are receiving life-extending drugs thanks to two major U.S. and international funds, double from a year ago, but many ...
Human immunodeficiency virus or HIV is a virus that makes your immune system so weak that it becomes hard for it to fight off even minor illnesses. That's why people affected by this virus get ...
But Will Canada Get into the Game? Thanks to a game-changing new drug, the race to end HIV and AIDS might finally be approaching the finish line. And the longer Canada warms the bench, the more our ...
The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS. The injectable drug lenacapavir was approved in June and is ...
A previous post reviewed data about drug use among sexual and gender minority people. In addition to its direct health risks, drug use is associated with an increased risk of HIV infection. It might ...